Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen® , for people living with HIV.
Michiko KogaTomoe SenkojiMegumi KubotaAya IshizakaTaketoshi MizutaniAyako SedoharaKazuhiko IkeuchiTadashi KikuchiEisuke AdachiMakoto SaitoTomohiko KoibuchiKazuyoshi HosomichiJun OhashiAi Kawana-TachikawaTetsuro MatanoTakeya TsutsumiHiroshi YotsuyanagiPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)
Three-dose of Aimmugen® for MSM-LWHIV was effective while two-dose was less effective compared to non-HIV-infected people. People-LWHIV with shorter duration of ART and lesser CD4 cell count achieved lower titers of anti-HA-IgG and might require an additional vaccination. This article is protected by copyright. All rights reserved.